Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

WT 4869

Next Previous
Search
Drug Profile

WT 4869

Alternative Names: WT4869

Latest Information Update: 05 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chugai Pharmaceutical; Dainippon Sumitomo Pharma
  • Developer Chugai Pharmaceutical; Sumitomo Pharma
  • Class Cancer vaccines; Peptide vaccines; Peptides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Myelodysplastic syndromes
  • No development reported Solid tumours
  • Discontinued Non-small cell lung cancer

Most Recent Events

  • 01 Apr 2022 Sumitomo Dainippon Pharma is now called Sumitomo Pharma
  • 28 Feb 2020 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease) in Japan (Intradermal)
  • 28 Feb 2020 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease) in Japan (SC)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top